Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:688198'
s EV-to-FCF Range Over the Past 10 Years
Min: -1527.54 Med: 244.03 Max: 5546.26
Current: 195.92
During the past 10 years, the highest EV-to-FCF of Beijing Balance Medical Technology Co was 5546.26. The lowest was -1527.54. And the median was 244.03.
SHSE:688198's EV-to-FCF is ranked worse than 92.51% of 414
companies
in the Medical Devices & Instruments industry
Industry Median: 22.995
vs SHSE:688198: 195.92
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Balance Medical Technology Co (SHSE:688198) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Balance Medical Technology Co's PE Ratio (TTM) for today is calculated as:
Beijing Balance Medical Technology Co's share price for today is ¥77.60.
Beijing Balance Medical Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.470.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Beijing Balance Medical Technology Co EV-to-FCF Related Terms
Beijing Balance Medical Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Balance Medical Technology Co EV-to-FCF Chart
SHSE:688198 vs ABT, SYK, MDT: EV-to-FCF Comparison
For the Medical Devices subindustry, Beijing Balance Medical Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Balance Medical Technology Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Beijing Balance Medical Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Beijing Balance Medical Technology Co's EV-to-FCF falls into.
Beijing Balance Medical Technology Co's current Enterprise Value is ¥10,826.4 Mil.
Beijing Balance Medical Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥55.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Balance Medical Technology Co (SHSE:688198) has a EV-to-FCF of 195.92 as of Jul. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Beijing Balance Medical Technology Co and its competitors. This is 20% below median its historical median of 244.03. According to the industry distribution chart, Beijing Balance Medical Technology Co ranks #383 out of 414 companies in the Medical Devices & Instruments industry, placing it in the top 92.5%.
Is Beijing Balance Medical Technology Co's EV-to-FCF too high?
Beijing Balance Medical Technology Co's current EV-to-FCF of 195.92 is 20% below median its 10-year median of 244.03. The Medical Devices & Instruments industry median EV-to-FCF is 23.00. Beijing Balance Medical Technology Co's value of 195.92 is 752% above this industry median. Based on the distribution chart, Beijing Balance Medical Technology Co ranks #383 out of 414 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Beijing Balance Medical Technology Co has a GF Score™ of 87/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Balance Medical Technology Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Beijing Balance Medical Technology Co ranks #383 out of 414 companies for EV-to-FCF. This places Beijing Balance Medical Technology Co in the lower half of its industry. The industry median EV-to-FCF is 23.00. Beijing Balance Medical Technology Co's value of 195.92 is 752% above this benchmark. While the company's 10-year median is 244.03 vs. the industry median of 23.00, Beijing Balance Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.00, based on 414 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Balance Medical Technology Co's current EV-to-FCF of 195.92 is 752% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Beijing Balance Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Balance Medical Technology Co's current EV-to-FCF is 195.92, which is 20% below median its own 10-year median of 244.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Balance Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co (SHSE:688198) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥185.28, compared to a current price of ¥77.60 — trading 58.1% below its estimated fair value. The current EV-to-FCF is 195.92, which is 20% below median its 10-year median of 244.03 and 752% above the Medical Devices & Instruments industry median of 23.00. Beijing Balance Medical Technology Co's overall GF Score™ is 87/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Beijing Balance Medical Technology Co (SHSE:688198), the current EV-to-FCF is 195.92 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Balance Medical Technology Co (SHSE:688198) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Balance Medical Technology Co stock appears to be undervalued.
The current stock price of ¥77.60 is trading 58.1% below its estimated GF Value™ of ¥185.28.
GuruFocus considers Beijing Balance Medical Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688198:
EV-to-FCF: 195.92 (20% below median its 10-year median of 244.03)
GF Value™: ¥185.28 vs. price of ¥77.60 (58.1% below fair value)
Industry Position: 752% above the Medical Devices & Instruments median (#383 of 414)
No single metric tells the full story. See the SHSE:688198 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Balance Medical Technology Co Business Description
Beijing Balance Medical Technology Co Ltd is engaged in the research and development and production of animal-derived implantable medical devices. The company's products are used in heart valve replacement and repair, congenital heart disease implant intervention and surgical soft tissue repair.
87GF Score
Get the complete analysis for SHSE:688198
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688198 has been successfully added to your 
